Cadrenal Therapeutics CVKD
NASDAQ CVKD
$0.99 +0.02 (+1.58%)
As of: Oct 2, 2026 · 9:57 AM EDT

Cadrenal Therapeutics (CVKD) Non Operating Income (2022 - 2026)

Updated

Cadrenal Therapeutics' Non Operating Income was $17,835 in Q2 2026, down 73.4% from $67,004 a year earlier.

Analysis

Cadrenal Therapeutics (CVKD) Non Operating Income (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Cadrenal Therapeutics' Non Operating Income was $210,604 through Jun 30, 2026, down 26.1% year-over-year; for FY2023, it was -$724,243.

  • In earlier years, Non Operating Income was -$4.01 million in FY2022.
  • The Q2 2026 figure marks the lowest quarterly Non Operating Income since Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Cadrenal Therapeutics 3.35 Mn -9.27 Mn - 17,835.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17,835.00
Jun 30, 2025 67,004.00
Sep 30, 2024 52,129.00
Jun 30, 2024 73,636.00
Mar 31, 2024 92,327.00
Dec 31, 2023 119,771.00
Sep 30, 2023 106,145.00
Jun 30, 2023 23,176.00
Mar 31, 2023 -973,335.00
Dec 31, 2022 -3.93 Mn
Sep 30, 2022 -53,323.00
Jun 30, 2022 -19,794.00
API Access

Cadrenal Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=CVKD&period=max&api_key=YOUR_API_KEY